Second primary malignancies in non-Hodgkin lymphoma: epidemiology and risk factors
Author:
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00277-023-05095-8.pdf
Reference86 articles.
1. Siegel RL, Miller KD, Fuchs HE et al (2021) Cancer statistics, 2021. CA Cancer J Clin 71:7–33
2. Howlader N (2022) SEER cancer statistics review 1975–2016. National Cancer Institute publishing the SEER web site. https://seer.cancer.gov/csr/1975_2016/. Accessed 28 Mar 2022
3. Liu W, Ji X, Song Y et al (2020) Improving survival of 3760 patients with lymphoma: experience of an academic center over two decades. Cancer Med 9:3765–3774
4. Brennan P, Scelo G, Hemminki K et al (2005) Second primary cancers among 109 000 cases of non-Hodgkin’s lymphoma. Br J Cancer 93:159–166
5. Tward JD, Wendland MM, Shrieve DC et al (2006) The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma. Cancer 107:108–115
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Characterization of second primary malignancies post CAR T-cell therapy: real-world insights from the two global pharmacovigilance databases of FAERS and VigiBase;eClinicalMedicine;2024-07
2. Construction and validation of a competing risk model for specific survival of patients with second primary malignancies after prostate cancer;2023-11-09
3. Correlation between lymphoma and second primary malignant tumor;Medicine;2023-05-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3